SilverCeuticals Inc.

CHEYENNE, WY · Founded 2021 · CIK 0001909363 · Biotech · Private

Nano-silver formulations for health and wellness products including immune support, cosmetics, oral care, and wound care

silverceuticals.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.0M
1 Form D · Mar 2022
56 months since last filing
Contracts
—
No federal contracts on record
Patents
7
0 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3304Syncromune, Inc.—$56M
3305TuHURA Biosciences, Inc.—$21M
3306Century Therapeutics—$160M
3307SilverCeuticals Inc.—$5.0M
3308ORF Biologics, Inc.—$2.5M
3309Blue Marlin Data Fund, LLC—$16M
3310ReNewVax Ltd—$3.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Kory DoppExecutive Officer
  • Cameron MoellerExecutive Officer
  • Keith MoellerExecutive Officer
  • Kirk MoellerExecutive Officer

Patents

USPTO · 0 granted of 7
  • Using Silver Compositions To Disinfect Surfacesapplication
  • Methods And Foods Including Silver Compounds To Protect Animals From Pathogenic Bacteria And Diseaseapplication
  • Using Silver Compounds To Protect Blood Cellsapplication
  • Using Silver Compositions To Disinfect Surfacesapplication
  • Using Silver Particles To Protect And/or Treat The Digestive System Of Fowl (livestock) From Pathogenic Bacteria And Diseaseapplication
  • Methods And Foods Including Silver Compounds To Protect Animals From Pathogenic Bacteria And Diseaseapplication
  • Using Silver Compounds To Protect And/or Treat The Digestive System And/or Respiratory System Of Livestock From Pathogenic Bacteria And Diseaseapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.